1. 1) The Japanese Association for Infectious Diseases, the Japanese Society of Chemotherapy, “The JAID/JSC guide to clinical management of infectious diseases”, Sanposha Printing, Tokyo, pp. 29-43 (2019).
2. 2) The Japanese Association for Infectious Diseases. the Japanese Society of Chemotherapy. “The practical guidelines for the management and treatment of infections caused by MRSA, 2019 Edition”: <http://www.kansensho.or.jp/uploads/files/guidelines/guideline_mrsa_2019revised-booklet.pdf >, cited 14 June, 2019.
3. 3) van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Sipahi OR, Brouwer MC, ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin. Microbiol. Infect., 22, S37–S62 (2016).
4. 4) The Japanese Society of Chemotherapy, the Japanese Society of Therapeutic Drug Monitoring. “Revised guidelines for therapeutic drug monitoring of antimicrobials”, cited June 2016.
5. 5) Wayne PA. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 21st informational supplement. CLSI document M100-S21 (2011).